Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Transactions of the American Clinical and Climatological Association|January 10, 2017
PRE-CLINICAL AND CLINICAL VALIDATION OF AN ANTI-CANCER MODALITY THAT ABLATES REFRACTORY, LOW GROWTH FRACTION TUMORSEric J Sorscher, Jeong S Hong, William B Parker
Pediatric Pulmonology|November 13, 2019
Cystic fibrosis precision therapeutics: Emerging considerationsDisha Joshi, Annette Ehrhardt, Jeong S Hong, et al.
Plos One|July 18, 2024
Mutation accumulation in H. sapiens F508del CFTR countermands dN/dS type genomic analysisJeong S Hong, Janice M Tindall, Samuel R Tindall, et al.
The Biochemical Journal|January 31, 2014
S-palmitoylation regulates biogenesis of core glycosylated wild-type and F508del CFTR in a post-ER compartmentMichelle L McClure, Hui Wen, James Fortenberry, et al.
Plos One|March 24, 2016
Robust Stimulation of W1282X-CFTR Channel Activity by a Combination of Allosteric ModulatorsWei Wang, Jeong S Hong, Andras Rab, et al.
The Journal of Gene Medicine|June 2, 2004
Hepatocyte growth factor stimulates adenoviral-mediated gene transfer across the apical membrane of epithelial cellsJason K Burrus, William D Matheson, Jeong S Hong, et al.
Cancer Chemotherapy and Pharmacology|July 5, 2012
In vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylaseEric J Sorscher, Jeong S Hong, Paula W Allan, et al.
BMC Medical Genomics|March 27, 2009
Correlation of microRNA levels during hypoxia with predicted target mRNAs through genome-wide microarray analysisJennifer S Guimbellot, Stephen W Erickson, Tapan Mehta, et al.
Scientific Reports|September 19, 2019
VX-770-mediated potentiation of numerous human CFTR disease mutants is influenced by phosphorylation levelGuiying Cui, Brandon B Stauffer, Barry R Imhoff, et al.
Pageof 5